Skip to main content
Top
Published in: Indian Journal of Pediatrics 11/2018

01-11-2018 | Original Article

Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial

Authors: N. B. Mathur, A. Murugesan

Published in: Indian Journal of Pediatrics | Issue 11/2018

Login to get access

Abstract

Objective

To compare the effect of 4 day course (study group) with 7 day course (control group) of antibiotic treatment in neonatal pneumonia, on treatment success rate.

Methods

This randomized controlled trial was conducted in a tertiary teaching hospital. Seventy, term and near-term neonates with pneumonia who had clinical remission by 48 h of antibiotic therapy were included. The neonates were randomized to receive a total of 4 d of antibiotics (Group 1) or 7 d of antibiotics (Group 2). The outcome measure was treatment failure in each group within 3 d of discharge.

Results

The treatment success rate of both the groups was 100%. There was a significant reduction in the duration of hospital stay (p < 0.001), antibiotic usage (p < 0.001), and cost (p < 0.001) in the 4 d group. On follow up till 28 d of enrollment, no infective morbidity was found in either group.

Conclusions

For term and near-term neonates who become clinically asymptomatic within 48 h of antibiotic therapy, 4 d of antibiotic therapy is as effective and safe as 7 d of antibiotic therapy, with significant reduction in hospital stay, antibiotic usage and cost.
Literature
1.
go back to reference Bang AT, Bang RA, Morankar VP, Sontakke PG, Solanki JM. Pneumonia in neonates: can it be managed in the community? Arch Dis Child. 1993;68:550–6.CrossRef Bang AT, Bang RA, Morankar VP, Sontakke PG, Solanki JM. Pneumonia in neonates: can it be managed in the community? Arch Dis Child. 1993;68:550–6.CrossRef
2.
go back to reference Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed. 2005;90:211–9.CrossRef Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed. 2005;90:211–9.CrossRef
3.
go back to reference Morrins AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis. 2014;6:101–12.CrossRef Morrins AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis. 2014;6:101–12.CrossRef
4.
go back to reference Wise R, Hart T, Cars O, et al. Antimicrobial resistance. Is a major threat to public health. BMJ. 1998;317:609–10.CrossRef Wise R, Hart T, Cars O, et al. Antimicrobial resistance. Is a major threat to public health. BMJ. 1998;317:609–10.CrossRef
5.
go back to reference Remington JS, Klein JO. Bacterial infections of the respiratory tract: pneumonia. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and the newborn infant. 7th ed. New York: Elsevier; 2011. p. 285–92. Remington JS, Klein JO. Bacterial infections of the respiratory tract: pneumonia. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and the newborn infant. 7th ed. New York: Elsevier; 2011. p. 285–92.
6.
go back to reference Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near term infants. Am J Perinatol. 2000;20:421–6.CrossRef Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near term infants. Am J Perinatol. 2000;20:421–6.CrossRef
8.
go back to reference Hengst JM. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care. 2003;3:1–13.CrossRef Hengst JM. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care. 2003;3:1–13.CrossRef
9.
go back to reference Chiesa C, Panero A, Rossi N, Stegagno M, Giusti MD, Osborn JF. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664–72.CrossRef Chiesa C, Panero A, Rossi N, Stegagno M, Giusti MD, Osborn JF. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664–72.CrossRef
10.
go back to reference Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97:165–74.CrossRef Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97:165–74.CrossRef
11.
go back to reference Mathur NB, Garg K, Kumar S. Respiratory distress in neonates with special reference to pneumonia. Indian Pediatr. 2002;39:529–37.PubMed Mathur NB, Garg K, Kumar S. Respiratory distress in neonates with special reference to pneumonia. Indian Pediatr. 2002;39:529–37.PubMed
12.
go back to reference Sivanandan S, Soriasham AS, Swarnam K. Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr. 2011;2011: 712150:9.CrossRef Sivanandan S, Soriasham AS, Swarnam K. Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr. 2011;2011: 712150:9.CrossRef
13.
go back to reference Cotton CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotising enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.CrossRef Cotton CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotising enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.CrossRef
14.
go back to reference Cotton CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr; National Institute for Child Health and Human Development Neonatal Research Network. The association of third generation cephalosporin use and invasive candidiasis in extremely low birth weight infants. Pediatrics. 2006;118:717–22.CrossRef Cotton CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr; National Institute for Child Health and Human Development Neonatal Research Network. The association of third generation cephalosporin use and invasive candidiasis in extremely low birth weight infants. Pediatrics. 2006;118:717–22.CrossRef
15.
go back to reference Saini SS, Dutta S, Ray P, Narang A. Short course versus 7-day course of intravenous antibiotics for probable neonatal septicaemia: a pilot, open label, randomized control trial. Indian Pediatr. 2011;48:19–24.CrossRef Saini SS, Dutta S, Ray P, Narang A. Short course versus 7-day course of intravenous antibiotics for probable neonatal septicaemia: a pilot, open label, randomized control trial. Indian Pediatr. 2011;48:19–24.CrossRef
16.
go back to reference Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis. J Trop Pediatr. 2006;52:427–32.CrossRef Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis. J Trop Pediatr. 2006;52:427–32.CrossRef
17.
go back to reference Gathwala G, Sindani A, Singh J, Choudhry O, Chaudhary U. Ten days vs 14 days antibiotic therapy in culture proven neonatal sepsis. J Trop Pediatr. 2010;56:433–5.CrossRef Gathwala G, Sindani A, Singh J, Choudhry O, Chaudhary U. Ten days vs 14 days antibiotic therapy in culture proven neonatal sepsis. J Trop Pediatr. 2010;56:433–5.CrossRef
18.
go back to reference Pasha YZ, Ahmadpour-Kacho M, Behmadi R, Jahangir T. 3-day versus 5-day course of intravenous antibiotics for suspected early onset neonatal sepsis: a randomized controlled trial. Iran J Pediatr. 2014;24:673–8.PubMedPubMedCentral Pasha YZ, Ahmadpour-Kacho M, Behmadi R, Jahangir T. 3-day versus 5-day course of intravenous antibiotics for suspected early onset neonatal sepsis: a randomized controlled trial. Iran J Pediatr. 2014;24:673–8.PubMedPubMedCentral
19.
go back to reference Mathur NB, Kharod P, Kumar S. Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial. J Trop Pediatr. 2015;61:119–25.CrossRef Mathur NB, Kharod P, Kumar S. Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial. J Trop Pediatr. 2015;61:119–25.CrossRef
20.
go back to reference Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34:263–73.CrossRef Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34:263–73.CrossRef
21.
go back to reference Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 1997;86:209–12.CrossRef Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 1997;86:209–12.CrossRef
22.
go back to reference Delèvaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62:337–40.CrossRef Delèvaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62:337–40.CrossRef
23.
go back to reference Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174:84–92.CrossRef Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174:84–92.CrossRef
Metadata
Title
Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial
Authors
N. B. Mathur
A. Murugesan
Publication date
01-11-2018
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 11/2018
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-018-2708-y

Other articles of this Issue 11/2018

Indian Journal of Pediatrics 11/2018 Go to the issue